TGT
5/8LiveTarget Corporation
NYSE · Healthcare · Medical Devices
$163.47
Blended fair value
$27.55
Well above fair value
Margin of safety
-493.32%
against blended fair value
Expected return
-8.39%
per year, mid case
52-week range
Valuation verdict
Based on your current assumptions
Well above fair value
Fair value $27.55 against a market price of $163.47.
- Margin of safety
- -493.32%
- Expected return
- -8.39%/ yr
Company facts
- Market cap
- $257.27B
- P/E (5yr avg)
- 129.3x
- Day range
- $161.20 – $166.75
- 52-week range
- $83.44 – $170.75
- Volume
- 6.2M
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 48,976
Fundamentals for this ticker are modelled rather than filed. Connect a financial-statements provider to replace these figures with reported data.
Falls short on 3 pillars: p/e ratio, price to free cash flow, long-term debt to fcf.
P/E ratio
Fail5yr average P/E below 22.5
Price to free cash flow
Fail5yr average P/FCF below 22.5
Return on invested capital
Pass5yr average ROIC above 9%
Revenue growth
Pass10yr CAGR above 0%
Net income growth
Pass10yr CAGR above 0%
Free cash flow growth
Pass10yr CAGR above 0%
Shares outstanding
PassShare count flat or shrinking over 5 years
Long-term debt to FCF
FailDebt payable from under 5 years of free cash flow
Everything Money is not an investment adviser. The fair-value range on this page is the arithmetic output of assumptions you control, not a forecast or a recommendation. Verify figures against the company's filings before acting. How the method works